Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 38,460 Tango Therapeutics, Inc. shares (Form 4)

Traded Apr 15, 2026 · Filed Apr 16, 2026

On Apr 15, 2026, Crystal Adam (President, R&D) sold 38,460 Tango Therapeutics, Inc. shares at US$25.00 for US$962K under a trading plan, leaving 112,622 shares. Filed Apr 16, 2026 (Form 4).

Sold: 38,460 shares
Price: US$25.00
Value: US$962K
Holding after: 112,622 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Apr 15, 2026	Common Stock	Option exercise	38,460	US$5.20	151,082	Direct
Apr 15, 2026	Common Stock	Sale	38,460	US$25.00	112,622	Direct

Source

View original at SEC

Related